BRANCATO, VIRGINIA
 Distribuzione geografica
Continente #
AS - Asia 2.466
NA - Nord America 1.956
EU - Europa 1.645
SA - Sud America 370
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 61
OC - Oceania 13
Totale 6.656
Nazione #
US - Stati Uniti d'America 1.866
SG - Singapore 819
IT - Italia 737
CN - Cina 569
HK - Hong Kong 317
BR - Brasile 276
VN - Vietnam 276
RU - Federazione Russa 224
FR - Francia 156
IE - Irlanda 107
DE - Germania 83
KR - Corea 81
IN - India 74
BD - Bangladesh 72
GB - Regno Unito 72
FI - Finlandia 57
CA - Canada 43
ID - Indonesia 42
NL - Olanda 39
AR - Argentina 38
TR - Turchia 37
JP - Giappone 34
SE - Svezia 31
ZA - Sudafrica 30
MX - Messico 28
PL - Polonia 24
IQ - Iraq 23
CO - Colombia 22
CH - Svizzera 17
PH - Filippine 17
ES - Italia 16
PT - Portogallo 16
PK - Pakistan 15
AT - Austria 14
SA - Arabia Saudita 14
CZ - Repubblica Ceca 13
UZ - Uzbekistan 12
TW - Taiwan 11
CL - Cile 10
AU - Australia 9
JO - Giordania 9
MA - Marocco 8
MY - Malesia 7
UA - Ucraina 7
IR - Iran 6
KE - Kenya 6
PY - Paraguay 6
EC - Ecuador 5
NP - Nepal 5
BO - Bolivia 4
DZ - Algeria 4
EG - Egitto 4
GR - Grecia 4
JM - Giamaica 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RO - Romania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BE - Belgio 3
CR - Costa Rica 3
DK - Danimarca 3
HR - Croazia 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GD - Grenada 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
DM - Dominica 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NO - Norvegia 1
QA - Qatar 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.512
Città #
Singapore 472
San Jose 348
Hong Kong 291
Milan 282
Ashburn 240
Hefei 150
Dublin 102
Ho Chi Minh City 102
Beijing 90
New York 79
Seoul 78
Dallas 77
Los Angeles 73
Chicago 70
Santa Clara 69
Hanoi 60
The Dalles 57
Rome 49
Buffalo 47
Council Bluffs 41
Helsinki 41
Lauterbourg 41
Jakarta 33
São Paulo 32
Moscow 23
Atlanta 22
Tokyo 21
Johannesburg 20
Turin 20
Shanghai 19
Frankfurt am Main 18
Warsaw 17
Columbus 16
Houston 16
Montreal 16
Chennai 15
Groningen 15
Guangzhou 15
London 15
Naples 15
Boardman 14
Bologna 14
Nuremberg 14
Baghdad 13
Da Nang 13
Orem 13
Tukwila 13
Denver 12
Florence 12
Munich 12
Braga 11
Hyderabad 11
Monza 11
Brooklyn 10
Salt Lake City 10
Washington 10
Zurich 10
Amman 9
Amsterdam 9
Dhaka 9
Figino 9
Istanbul 9
Tashkent 9
Ankara 8
Phoenix 8
Rio de Janeiro 8
Brescia 7
Buenos Aires 7
Riyadh 7
Biên Hòa 6
Boston 6
Brno 6
Busto Arsizio 6
Bắc Ninh 6
Chengdu 6
Falkenstein 6
Ha Long 6
Lahore 6
Manchester 6
Mexico City 6
Poplar 6
Seattle 6
Toronto 6
Vienna 6
Berlin 5
Cagliari 5
Charlotte 5
City of London 5
Curitiba 5
Detroit 5
Duque de Caxias 5
Haiphong 5
Lewistown 5
Milwaukee 5
Mumbai 5
Nairobi 5
Philadelphia 5
Pittsburgh 5
Querétaro 5
Quận Bình Thạnh 5
Totale 3.679
Nome #
Chitosan-Based Biomaterials: Insights into Chemistry, Properties, Devices, and Their Biomedical Applications 404
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 293
Mechanical Property of Hydrogels and the Presence of Adipose Stem Cells in Tumor Stroma Affect Spheroid Formation in the 3D Osteosarcoma Model 270
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 267
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 258
3D Bioprinting for Cancer Models 237
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 229
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 208
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 203
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 184
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 179
Tumor-Associated Protrusion Fluctuations as a Signature of Cancer Invasiveness 176
Synergistic Effect of Co-Culturing Breast Cancer Cells and Fibroblasts in the Formation of Tumoroid Clusters and Design of In Vitro 3D Models for the Testing of Anticancer Agents 161
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 159
Convection patterns gradients of non-living and living micro-entities in hydrogels 158
Could 3D models of cancer enhance drug screening? 158
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 155
Silk fibroin promotes mineralization of gellan gum hydrogels 153
Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model 151
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meeting 142
3D cancer spheroids and microtissues 141
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 132
adipoSIGHT in Therapeutic Response: Consequences in Osteosarcoma Treatment 131
Tumor-stroma interactions alter the sensitivity of drug in breast cancer 130
Coupling Micro-Physiological Systems and Biosensors for Improving Cancer Biomarkers Detection 128
Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer 125
Design of inhibitors of influenza virus membrane fusion: Synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series 122
An Engineered Breast Cancer Model on a Chip to Replicate ECM-Activation In Vitro during Tumor Progression 121
3D is not enough: Building up a cell instructive microenvironment for tumoral stroma microtissues 115
Bioengineered Tumoral Microtissue: An In Vitro 3D Platform To Investigate Cell-ECM Interaction And Cancer Development 113
3D tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems 107
Decellularized matrices for tumor cell modeling 105
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 105
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 104
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 104
Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-Methylfunicone from Penicillium pinophilum and cisplatin 103
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 102
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 100
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 95
3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro 89
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 85
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 81
A straightforward method to produce decellularized dermis-based matrices for tumour cell cultures 73
Totale 6.656
Categoria #
all - tutte 23.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023249 0 0 0 0 45 72 47 29 6 18 19 13
2023/2024458 12 7 24 53 47 71 76 23 62 6 16 61
2024/20251.402 63 149 82 78 116 78 122 60 96 191 132 235
2025/20264.334 361 298 450 479 483 281 510 150 384 367 174 397
2026/2027213 213 0 0 0 0 0 0 0 0 0 0 0
Totale 6.656